US Stock MarketDetailed Quotes
ALNY Alnylam Pharmaceuticals
- 244.890
- -1.910-0.77%
Close Nov 22 16:00 ET
- 244.400
- -0.490-0.20%
Post 20:01 ET
31.59BMarket Cap-93469P/E (TTM)
248.900High243.350Low526.15KVolume248.900Open246.800Pre Close129.12MTurnover0.41%Turnover RatioLossP/E (Static)128.98MShares304.39052wk High975.66P/B31.45BFloat Cap141.97552wk Low--Dividend TTM128.44MShs Float304.390Historical High--Div YieldTTM2.25%Amplitude3.650Historical Low245.398Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Alnylam Pharmaceuticals Stock Forum
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024 | ALNY Stock News
ALNY BUY ALERT 🚨 DRUG NEWS MULTIPLE PRICE TARGET RAISES
No comment yet